Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCeres Power Regulatory News (CWR)

Share Price Information for Ceres Power (CWR)

Share Price is delayed by 15 minutes
Get Live Data
609.50    -40.50 (-6.23%)
Bid:
606.50
Ask:
614.50
Spread: 8.00 (1.319%)
Market Cap: £1.19b
CWR Live PriceLast checked at - London Stock Exchange

Intraday Ceres Power Share Chart

Holding(s) in Company

26 Oct 2012 10:54

RNS Number : 6321P
Ceres Power Holdings plc
26 October 2012
 



 

 

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

 

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Ceres Power Holdings PLC

 

2 Reason for the notification (please tick the appropriate box or boxes):

 

An acquisition or disposal of voting rights

X

 

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

 

An event changing the breakdown of voting rights

 

Other (please specify):

 

3. Full name of person(s) subject to the notification obligation:

 

OppenheimerFunds, Inc.

4. Full name of shareholder(s) (if different from 3.):

 

5. Date of the transaction and date on which the threshold is crossed or reached:

 

October 24, 2012

6. Date on which issuer notified:

 

October 25, 2012

7. Threshold(s) that is/are crossed or reached:

 

5% (decreased to 2.19%)

 

8. Notified details:

A: Voting rights attached to shares

 

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

5,432,764

5,432,764

1,885,000

1,885,000

2.19%

GB00B0351429

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

 

Type of financialinstrument

Expirationdate

Exercise/ConversionPeriod

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

 

% of votingrights

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

 

Type of financialinstrument

Exerciseprice

Expirationdate

Exercise/Conversionperiod

Number of votingrights instrumentrefers to

% of voting rights

 

Nominal

Delta

 

 

Total (A+B+C)

 

Number of voting rights

Percentage of voting rights

1,885,000

2.19%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable:

 

 OppenheimerFunds, Inc. ("OFI") is a registered investment advisor with the U.S. SEC. Its ultimate parent company, Massachusetts Mutual Life Insurance Company, qualifies for disaggregation under FSA regulations. The shares of the issuer are held by investment accounts managed by OFI.

 

Proxy Voting:

 

10. Name of the proxy holder:

 

11. Number of voting rights proxy holder will cease to hold:

 

12. Date on which proxy holder will cease to hold voting rights:

 

 

13. Additional information:

 

14. Contact name:

 

Jake Burford, Manager Compliance,

OppenheimerFunds. Inc.

15. Contact telephone number:

 

001(303)766-2826

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUNOKRUVARURA
Date   Source Headline
9th Jun 20264:58 pmRNSRetail Offer by RetailBook
9th Jun 20264:56 pmRNSProposed capital raise of approx. £100million
1st Jun 20264:00 pmRNSHolding(s) in Company
29th May 202610:00 amRNSTotal Voting Rights
14th May 20263:31 pmRNSDirectorate change
14th May 20263:30 pmRNSResult of AGM
8th May 20263:30 pmRNSHolding(s) in Company
8th May 20263:30 pmRNSGrant of Share Options under the Sharesave Scheme
8th May 202610:30 amRNSHolding(s) in Company
6th May 20269:00 amRNSHolding(s) in Company
5th May 202611:15 amRNSHolding(s) in Company
1st May 20261:15 pmRNSDirector/PDMR Shareholding
1st May 202610:00 amRNSHolding(s) in Company
30th Apr 20261:20 pmRNSHolding(s) in Company
30th Apr 20261:20 pmRNSHolding(s) in Company
30th Apr 202610:00 amRNSTotal Voting Rights
30th Apr 20267:00 amRNSDelta Electronics & Centrica partnership
29th Apr 202611:00 amRNSHolding(s) in Company
21st Apr 20267:00 amRNSChange of Adviser
17th Apr 20262:30 pmRNSGrant of Long Term Incentive Plan (“LTIP”) Awards
15th Apr 202610:30 amRNSCapital markets event
14th Apr 202611:00 amRNSNotice of AGM & Publication of Annual Report
31st Mar 202610:00 amRNSTotal Voting Rights
26th Mar 20267:02 amRNSCeres and Centrica sign a strategic partnership
26th Mar 20267:00 amRNSFinal results for the year ended 31 December 2025
23rd Mar 20267:00 amRNSNotice of Capital Markets Event
9th Mar 202611:00 amRNSHolding(s) in Company
27th Feb 202612:00 pmRNSTotal Voting Rights
24th Feb 20267:00 amRNSNotice of Results
20th Feb 20269:30 amRNSHolding(s) in Company
16th Feb 20261:00 pmRNSHolding(s) in Company
5th Feb 20266:15 pmRNSHolding(s) in Company
4th Feb 202612:00 pmRNSHolding(s) in Company
30th Jan 202610:00 amRNSTotal Voting Rights
9th Jan 20262:00 pmRNSBlock listing Interim Review
8th Jan 20264:45 pmRNSHolding(s) in Company
6th Jan 202612:00 pmRNSHolding(s) in Company
31st Dec 202510:00 amRNSTotal Voting Rights
31st Dec 202510:00 amRNSTotal Voting Rights
18th Dec 20254:30 pmRNSHolding(s) in Company
18th Dec 20254:30 pmRNSHolding(s) in Company
15th Dec 20252:30 pmRNSHolding(s) in Company
28th Nov 202510:00 amRNSTotal Voting Rights
6th Nov 20253:10 pmRNSHolding(s) in Company
5th Nov 20257:00 amRNSWeichai signs manufacturing licence for SOFC power
31st Oct 20254:15 pmRNSHolding(s) in Company
31st Oct 202510:00 amRNSTotal Voting Rights
27th Oct 20256:00 pmRNSAlpha Group International
15th Oct 202510:00 amRNSHolding(s) in Company
7th Oct 20259:30 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.